tiprankstipranks
InterCure (INCR)
NASDAQ:INCR
Holding INCR?
Track your performance easily

Intercure (INCR) Technical Analysis

88 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
4Neutral
8Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
InterCure’s (INCR) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting InterCure is a Sell.
InterCure’s (INCR) 20-Day exponential moving average is 1.41, while InterCure’s (INCR) share price is $1.49, making it a Buy.
InterCure’s (INCR) 50-Day exponential moving average is 1.52, while InterCure’s (INCR) share price is $1.49, making it a Sell.

Intercure (INCR) Pivot Points

Dec 22, 2024, 11:54 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.22
1.28
1.31
1.37
1.40
1.46
1.49
Fibonacci
1.28
1.31
1.34
1.37
1.40
1.43
1.46
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Intercure (INCR) Moving Averages

Dec 22, 2024, 11:54 PM
Period
Simple
Exponential
MA5
1.42Buy
1.42Buy
MA10
1.40Buy
1.41Buy
MA20
1.39Buy
1.41Buy
MA50
1.52Sell
1.52Sell
MA100
1.74Sell
1.70Sell
MA200
2.14Sell
1.89Sell
InterCure’s (INCR) 10-Day exponential moving average is 1.41, while InterCure’s (INCR) share price is $1.49, making it a Buy.
InterCure’s (INCR) 100-Day exponential moving average is 1.70, while InterCure’s (INCR) share price is $1.49, making it a Sell.
InterCure’s (INCR) stock price is $1.49 and InterCure’s (INCR) 50-day simple moving average is 1.52, creating a Sell signal.
InterCure’s (INCR) stock price is $1.49 and InterCure’s (INCR) 100-day simple moving average is 1.74, creating a Sell signal.
InterCure’s (INCR) stock price is $1.49 and InterCure’s (INCR) 200-day simple moving average is 2.14, creating a Sell signal.

Intercure (INCR) Technical Indicators

Dec 22, 2024, 11:54 PM
Name
Value
Implied Action
RSI (14)
54.21
Neutral
STOCH (9,6)
51.35
Neutral
STOCHRSI (14)
49.42
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
19.40
Buy
Williams %R
-40.63
Buy
CCI (14)
198.06
Sell
ATR (14)
0.10
-
Ultimate Oscillator
49.54
Neutral
ROC
13.74
Buy
InterCure’s (INCR) Relative Strength Index (RSI) is 54.21, creating a Neutral signal.
InterCure’s (INCR) Trend Strength Indicator (ADX) is 19.40, creating a Buy signal.
InterCure’s (INCR) Commodity Channel Index (CCI) is 198.06, creating a Sell signal.
InterCure’s (INCR) Price Rate of Change (ROC) is 13.74, creating a Buy signal.

FAQ

Is INCR a Buy, Hold, or Sell?
Based on INCR’s technical indicators, INCR is a Hold.
    What is INCR’s RSI (14)?
    INCR’s RSI (14) is 54.21, which suggests INCR is a Neutral.
      What is INCR’s MACD?
      INCR’s MACD is -0.02, which suggests INCR is a Sell.
        What is INCR’s 5-day moving average?
        INCR’s 5-day moving average is 1.42, which suggests INCR is a Buy.
          What is INCR’s 20-day moving average?
          INCR 20-day moving average is 1.39, which suggests INCR is a Buy.
            What is INCR’s 50-day moving average?
            INCR’s 50-day moving average is 1.52, which suggests INCR is a Sell.
              What is INCR’s 200-day moving average?
              INCR’s 200-day moving average is 2.14, which suggests INCR is a Sell.
                What is INCR’s Williams % R (14)?
                INCR’s Williams % R (14) is -40.63, which suggests INCR is a Buy.
                  What is INCR’s CCI (14)?
                  INCR’s CCI (14) is 198.06, which suggests INCR is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis